Pieter Jan Vos, MSc – Chief Executive Officer, co-founder
Pieter Jan received his M.Sc. in Chemistry from Leiden University and graduated from ESCP Europe, School of Management, Paris, France. Pieter Jan is former Director New Business Active Pharmaceutical Ingredients at Diosynth / Organon, Oss, The Netherlands. He subsequently founded Amspar BV, a company that focuses on global licensing of generic pharmaceuticals. Pieter Jan became involved in MyLife Technologies in 2011, half a year before the company’s incorporation.
Koen van der Maaden, PhD – Development Officer
Koen obtained a Bachelor degree in Pharmacy from Utrecht University in 2008. He studied Biopharmaceutical Sciences at Leiden University between 2008 and 2010 and completed his Masters Degree with honors. In 2014 Koen obtained his PhD on micro-needle technologies for vaccine delivery and he has rapidly become an internationally known specialist in microneedle research. Since June 2015, Koen is heading MLT’s lab in Leiden.
Nico Kuijt, BSc – Research Analyst
Nico obtained a Bachelor degree in Analytical Chemistry from Hogeschool Leiden in 2011. In January 2012, he started as associate scientist at to-BBB, Leiden, The Netherlands, working on the development and analysis of liposomal drug formulations. In February 2015, he started as associate scientist at Janssen Biologics, Leiden, The Netherlands, working on the analysis of a variety of drug formulations. In June 2015, he started at MyLife Technologies as Research Analyst currently working on the development and analysis of various nanoporous microneedle array formulations.
Regina Lüttge, PhD
Regina received her PhD from University of London, Imperial College, on Microsystems Technology in 2003. In her scientific profile as associate professor in the Microsystems Group, Mechanical Engineering department at Eindhoven University of Technology, she mainly works on microsystems for life-science applications with an emphasis on miniaturized cell culture disease models supported financially by the ERC. Previously during her career at University of Twente (UT), Regina contributed to the creation of med-tech startup Medimate B.V. Together with her research team at UT, she has laid the foundation for the business case for UT’s patented npMNA technology.
Henk Viëtor, M.D., PhD
Henk Viëtor is a medical doctor and scientists by training, specialized in clinical immunology, transfusion medicine and clinical genetics. His scientific results were published in numerous leading scientific journals including Nature. He is inventor on several patents.
Since he co-founded Drug Discovery Factory in 2000, he has been an active entrepreneur and co-founder of 10 Life Sciences start-up companies. He is also on the board of the Center for Translational Medicine.